This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Estelles, A. Articles by Loskutoff, D. J. Search for Related Content PubMed PubMed Citation Articles by Estelles, A. Articles by Loskutoff, D. J.

American Journal of Pathology, Vol 149, 1229-1239, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease

A Estelles, S Grancha, J Gilabert, T Thinnes, M Chirivella, F Espana, J Aznar and DJ Loskutoff
Centro de Investigation, Hospital Universitario La Fe, Valencia, Spain.

We previously reported significantly elevated levels of plasminogen activator inhibitor type 1 (PAI-1) in plasma and placenta from pregnant women with severe pre-eclampsia, and pre-eclampsia is a frequent problem in molar pregnancies. As increases in PAI-1 may contribute to the placental alterations that occur in pre-eclampsia, we have begun to investigate changes in PAI-1 as well as PAI-2 and several other components of the fibrinolytic system in patients with trophoblastic disease. Significant increases in plasma PAI-1 and decreases in plasma PAI-2 levels were observed in molar pregnancies when compared with the levels in normal pregnant women of similar gestational age. PAI-1 antigen levels also were increased, and PAI-2 levels were decreased in placenta from women with molar pregnancies compared with placenta obtained by spontaneous abortion. Immunohistochemical analysis revealed strong positive and specific staining of PAI-1 in trophoblastic epithelium in molar pregnancies and relatively weak staining of PAI-2. No association between the distribution of PAI-1 and vitronectin was found, and no specific signal for tissue type PA, urokinase type PA, tumor necrosis factor-alpha, or interleukin-1 was detected. In situ hybridization revealed an increase in PAI-1 but not PAI-2 mRNAs in placenta from molar pregnancies in comparison with placenta from abortions. These results demonstrate increased PAI-1 protein and mRNA in trophoblastic disease and suggest that localized elevated levels of PAI-1 may contribute to the hemostatic problems associated with this disorder.

This article has been cited by other articles:

				Y. Purwosunu, A. Sekizawa, K. Koide, A. Farina, N. Wibowo, G. H. Wiknjosastro, S. Okazaki, H. Chiba, and T. Okai Cell-Free mRNA Concentrations of Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator Are Increased in the Plasma of Pregnant Women with Preeclampsia Clin. Chem., March 1, 2007; 53(3): 399 - 404. [Abstract] [Full Text] [PDF]

				D. Thumkeo, J. Keel, T. Ishizaki, M. Hirose, K. Nonomura, H. Oshima, M. Oshima, M. M. Taketo, and S. Narumiya Targeted Disruption of the Mouse Rho-Associated Kinase 2 Gene Results in Intrauterine Growth Retardation and Fetal Death Mol. Cell. Biol., July 15, 2003; 23(14): 5043 - 5055. [Abstract] [Full Text] [PDF]

				F. VESCE, C. SCAPOLI, G. GIOVANNINI, A. PIFFANELLI, A. GEURTS-MOESPOT, and F. C. G. J. SWEEP Plasminogen Activator System in Serum and Amniotic Fluid of Euploid and Aneuploid Pregnancies Obstet. Gynecol., March 1, 2001; 97(3): 404 - 408. [Abstract] [Full Text] [PDF]

				C. J. GLUECK, M. J. KUPFERMINC, R. N. FONTAINE, P. WANG, B. B. WEKSLER, and A. ELDOR Genetic Hypofibrinolysis in Complicated Pregnancies Obstet. Gynecol., January 1, 2001; 97(1): 44 - 48. [Abstract] [Full Text] [PDF]